Humira Biosimilars Market Segmentation by Product, Indication, Distribution Channel, and End User
The global Humira Biosimilars Market is projected to increase from USD 9.6 billion in 2026 to USD 23.8 billion by 2036, registering a compound annual growth rate (CAGR) of 9.5%, according to Future Market Insights (FMI). Growth is supported by healthcare systems transitioning patients from the reference biologic to lower-cost adalimumab alternatives, alongside wider availability of...
0 Commenti 0 condivisioni 12 Views 0 Anteprima